CoChat

HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer

Open access
Jackson, Autumn L, Zhou, Bing, Kim, William Y · 2010 · Expert Opinion on Therapeutic Targets
Cited by 78

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

IMPORTANCE OF THE FIELD: The role of angiogenesis in the initiation and progression of NSCLC and the molecular alterations leading to the growth of tumor vasculature are areas of great interest and recent therapeutic success. AREAS COVERED IN THIS REVIEW: VEGF and its receptors play critical roles in the development of tumor vasculature and can be targeted by agents such as bevacizumab in the treatment of NSCLC. Furthermore, tumor hypoxia and the expression of the hypoxia-inducible factor (HIF) family of proteins are also linked to poorer survival in these patients. Recent studies using genetically engineered mouse models expressing stabilized HIF validate the importance of HIF in the evolution of NSCLC and demonstrate genetically that HIF is involved in NSCLC. WHAT THE READER WILL GAIN: An overview of the key pathways and mediators of tumor angiogenesis, their relevance to the pathogenesis of NSCLC, and an update on the current status of angiogenesis inhibitors in NSCLC. TAKE HOME MESSAGE: Angiogenesis is a key mediator of NSCLC progression. Several antiangiogenic strategies are in clinical use and under development. While candidate predictive biomarkers of response to antiangiogenic therapy exist, they await independent and prospective validation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/14728222.2010.511617

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 78

Metadata

Authors
Jackson, A. L., Zhou, B., & Kim, W. Y.
Venue
Expert Opinion on Therapeutic Targets
Published
2010-09-20
Volume
14
Issue
10
Pages
1047-1057
ISSN
  • 1472-8222 (ISSN-L)
  • 1744-7631
OpenAlex
W2119490571
Cited by
78
References
18
FWCI
1.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer. https://app.cochat.ai/papers/10.1517/14728222.2010.511617
The paper
Jackson, A. L., Zhou, B., & Kim, W. Y. (2010). HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer. Expert Opinion on Therapeutic Targets. https://doi.org/10.1517/14728222.2010.511617

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.